AltaThera Pharmaceuticals, a pharmaceutical company focused on pioneering therapies to address critical gaps in cardiac care, today announced its active participation in the upcoming 35th Annual International Symposium on Adult Congenital Heart Disease hosted by the Cincinnati Children’s Heart Institute at the Hyatt Regency in downtown Cincinnati, Ohio, June 3-6, 2026.
Attendees are welcome to stop by the AltaThera booth to learn more about our company and Sotalol IV. Schedule a meeting with us in advance by contacting us at https://www.altathera.com/contact.
Learn more about the symposium here: https://www.cincyhearteducationseries.org/achd2026.
BOXED WARNING: Life-Threatening Proarrhythmia. Please see full prescribing information including boxed warning, contraindications, and dosing, at www.altathera.com/sotalol-iv-pi/.